Description:

Otrivin Paediatric Nasal Drops are formulated to provide relief from nasal congestion in children aged 1 to 11 years. The active ingredient, xylometazoline hydrochloride, works by narrowing the blood vessels in the nasal passages, reducing swelling and congestion.

Prescription:

• Over-the-counter 

Dosage:

• Children 1 to 5 years: 1 to 2 drops into each nostril, once or twice daily (every 8 to 10 hours). Do not exceed 3 applications daily per nostril.
• Children 6 to 11 years: 2 to 4 drops into each nostril, 2 to 3 times daily as needed. Do not exceed 3 applications daily per nostril.

It is recommended to make the last application shortly before bedtime. Do not use for more than 10 consecutive days.

Therapeutic Category:

• Nasal decongestant.

Active Ingredients/Composition:

• Each millilitre contains 0.5 mg of xylometazoline hydrochloride.

Variant:

• Otrivin Paediatric Nasal Drops are available in a 0.05% w/v solution.

Consume Type:

• Topical nasal administration.

Directions/Usage:

1. Gently clear the child’s nose.
2. Remove the bottle cap.
3. Tilt the child’s head back as far as comfortable or, if lying down, hang the head over the side of the bed.
4. Without touching the nozzle to the nose, apply the drops into each nostril and keep the head tilted back for a short time to allow the drops to spread throughout the nose.
5. Replace the cap right after use.
6. Clean and dry the nozzle before replacing the cap to avoid contamination.
7. To prevent the spread of infection, the bottle should only be used by one person. 

Common Side Effects:

• Nasal irritation or dryness.
• Sneezing.
• Rarely, systemic effects such as headache, nausea, or palpitations may occur.

If any adverse effects occur, discontinue use and consult a healthcare professional.

Package Type:

• Typically available in a 10 ml bottle with a dropper for nasal administration.

Storage Advice:

• Store below 30°C.
• Protect from heat.
• Keep out of reach and sight of children. 

Safety Advice:

• Do not use in children under 1 year of age.
• Do not exceed the recommended dosage.
• Use with caution in children with hypertension, cardiovascular disease, hyperthyroidism, diabetes mellitus, or prostatic hypertrophy.
• Consult a doctor before use if the child has undergone recent nasal surgery.
• Prolonged use may cause rebound congestion. 

Product Substitutes:

• Alternative paediatric nasal decongestants include saline nasal drops or sprays. Consult a healthcare professional for suitable options.

Manufacturer/Marketer:

• GlaxoSmithKline Consumer Healthcare.

Country of Origin:

• Switzerland